Cytokinetics

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.
Purchase on Scientist.com

The Latest Insights & Innovations from

Cytokinetics

Webinar

APS Physiology in Disease Modeling and Drug Development Roundtable

January 24, 2023
Learn more
No items found.
No items found.